Knobbe, Martens, Olson & Bear, LLP
Immunity enhancing therapeutic vaccine for HPV and related diseases
An immunity enhancing therapeutic vaccine includes a gene vector based on recombinant adenovirus and three elements: 1) an HPV antigen including the E6 and E7 multivalent fusion proteins of HPV types 16 and 18, 2) an immunologic adjuvant protein fused with said antigen, which protein may be a heat shock protein (HSP) of Mycobacterium tuberculosis, and 3) an immunostimulant, which may be granulocyte-macrophage colony stimulating factor (GM-CSF). The vaccine is used for the treatment of human papilloma virus infections and related diseases.
MYGT Biopharmaceutical LLC
C C A A A A C C C C A A A C A C A A
C07K C12N A61K A61P A61P A61K C12N C07K C12N C12N A61P A61K A61P C07K A61K C12N A61P A61P
inventional additional additional inventional inventional additional inventional inventional additional additional inventional inventional inventional inventional inventional additional inventional inventional
Tao Juan Xiao
Bian Li Xiao